| Application no. and date | 11817532.2 (espacenet) (Federated) (European Patent Register), 20111213 | | Patent/reg. no. and date | DK/EP 2790715, 20161207 | | Publication date | 20141022 | | Priority no. and date | | | EP pub. no. and date |
EP 2790715 20141022 | | Effective date | | | Applicant/owner | Centre National De La Recherche Scientifique, 3, rue Michel-Ange
75794 Paris Cedex 16, FR,
ImmuPharma France SA, 5 rue du Rhône
68100 Mulhouse, FR | | Applicant ref. no. | V138899 | | Inventor | MULLER, Sylviane, 4, quai Rouger de l'Isle
67000 Strasbourg, FR,
BRIAND, Jean-Paul, 4, quai Rouger de l'Isle
67000 Strasbourg, FR,
ZIMMER, Robert, 5, rue du Rhône
68100 Mulhouse, FR | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 38/04 (2006.01) , C07K 7/08 (2006.01) | | Title | MODIFICEREDE PEPTIDER OG ANVENDELSE HERAF TIL BEHANDLING AF
AUTOIMMUNE SYGDOMME | | Int. application no. | IB2011003256 | | Int. publication no. | WO2013088194 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
